CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on individualized cell-based immunotherapies. CellVax Therapeutics has developed a proprietary personalized tumor cell-based cancer immuno-therapy platform.
The company has completed Phase I and Phase II clinical trial in Brazil and has initiated (Oct 24) a Phase II Adaptive Design Trial for patients with high-risk prostate cancer. https://clinicaltrials.gov/study/NCT06636682
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1951 Nw 7th Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellvx.com
- Keywords
- Cell-based Therapy, Solid Tumors, Autologous Vaccine, MHC II, FK-PC101, Prostate Cancer, Prostate Cancer Vaccine, Immunotherapy.
- HQ
- Miami, Florida
Cellvax Therapeutics, Inc. Questions
Cellvax Therapeutics, Inc.'s website is http://www.cellvx.com
Cellvax Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cellvax-therapeutics
Cellvax Therapeutics, Inc. has
2 employees.
View email and phone details for 2
employees at Cellvax Therapeutics, Inc..
Cellvax Therapeutics, Inc.'s industry is
Biotechnology Research
Cellvax Therapeutics, Inc.'s top competitors are
Cellvax,
Cellipont Bioservices,
Ctrl Therapeutics,
Wow Aceleradora De Startups,
Blossomhill Therapeutics, Inc.,
Gensco Pharma,
Immorta Bio,
Myosin Therapeutics Inc.,
Theragent Inc,
Simcere Pharmaceutical Group.
Cellvax Therapeutics, Inc.'s categories are Biotechnology Research
Cellvax Therapeutics, Inc.'s founding year is 2020
